VIVEVE MED INC's ticker is VIVE and the CUSIP is 92852W204. A total of 11 filers reported holding VIVEVE MED INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,703,000 | -59.6% | 4,480,565 | 0.0% | 0.09% | -68.3% |
| Q1 2019 | $4,211,000 | -10.5% | 4,480,565 | 0.0% | 0.29% | -34.5% |
| Q4 2018 | $4,705,000 | -44.2% | 4,480,565 | +42.4% | 0.44% | -13.3% |
| Q3 2018 | $8,435,000 | +8.4% | 3,147,232 | +10.0% | 0.50% | -10.0% |
| Q2 2018 | $7,782,000 | -16.9% | 2,861,023 | +11.9% | 0.56% | -37.0% |
| Q1 2018 | $9,361,000 | +12.6% | 2,557,559 | +52.9% | 0.89% | -35.8% |
| Q4 2017 | $8,315,000 | +7.7% | 1,672,998 | +13.6% | 1.39% | +3.3% |
| Q3 2017 | $7,719,000 | -13.3% | 1,473,028 | +18.8% | 1.34% | -28.4% |
| Q2 2017 | $8,899,000 | +22.7% | 1,239,443 | +8.2% | 1.88% | -1.7% |
| Q1 2017 | $7,253,000 | +67.7% | 1,145,736 | +36.5% | 1.91% | +17.3% |
| Q4 2016 | $4,324,000 | -28.6% | 839,666 | +0.0% | 1.63% | -11.1% |
| Q3 2016 | $6,060,000 | +81.4% | 839,274 | +3.0% | 1.83% | +60.5% |
| Q2 2016 | $3,341,000 | – | 814,946 | – | 1.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,849,711 | $10,471,000 | 6.36% |
| RTW INVESTMENTS, LP | 2,861,023 | $7,782,000 | 0.56% |
| Nantahala Capital Management | 3,948,132 | $10,739,000 | 0.44% |
| Granahan Investment Management | 792,607 | $2,156,000 | 0.13% |
| ACUTA CAPITAL PARTNERS, LLC | 267,500 | $728,000 | 0.13% |
| KNOTT DAVID M | 71,449 | $194,000 | 0.07% |
| WEXFORD CAPITAL LP | 349,100 | $950,000 | 0.06% |
| HighTower Advisors, LLC | 1,821,456 | $4,957,000 | 0.04% |
| MEITAV INVESTMENT HOUSE LTD | 310,000 | $800,000 | 0.04% |
| J. Goldman & Co LP | 221,000 | $601,000 | 0.03% |